Treatment Options for Refractory Childhood Constipation

Nader N. Youssef1, Carlo Di Lorenzo

  • 1Children's Hospital of Pittsburgh, 3705 Fifth Avenue at DeSoto Street, Pittsburgh, PA 15213, USA. Carlo.DiLorenzo@CHP.edu

Insights

Childhood constipation is common, with most cases resolving within two years using therapies or behavioral changes. Persistent constipation requires further evaluation to identify causes and guide treatment strategies.

Area of Science:

  • Pediatric Gastroenterology
  • Child Health

Background:

  • Childhood constipation is a prevalent condition affecting many families.
  • Untreated constipation can lead to fecal incontinence, impactions, and emotional distress.
  • Refractory constipation significantly impacts a child's daily life and family well-being.

Purpose of the Study:

  • To outline the classification and management of persistent constipation in children.
  • To emphasize the need for thorough evaluation in refractory cases.
  • To discuss diverse therapeutic approaches for pediatric constipation.

Main Methods:

  • Categorization of persistent constipation into functional, enteric neuromuscular disorders, or neurologic handicaps.
  • Review of current and novel treatment strategies.
  • Emphasis on comprehensive diagnostic evaluations for complex cases.

Main Results:

  • Approximately 70% of children achieve successful outcomes within two years with standard therapies.
  • Persistent constipation necessitates advanced medical and behavioral interventions.
  • Some children may benefit from surgical interventions for refractory constipation.

Conclusions:

  • Effective management of childhood constipation often requires tailored, aggressive interventions.
  • Understanding the underlying cause is crucial for successful treatment.
  • A range of therapeutic options, including novel approaches, are available for pediatric constipation.

Related Concept Videos

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD: